Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.
Yomna M NassarNicolas HohmannRobin MicheletKatharina GottwaltAndreas D MeidJürgen BurhenneWilhelm HuisingaWalter Emil HaefeliGerd MikusCharlotte KloftPublished in: Clinical pharmacokinetics (2022)
The trial was registered at the European Union Drug Regulating Authorities for Clinical Trials (EudraCT-No. 2013-004869-14).